Magnolia Bark
Magnolia officinalis (Magnolia Bark Extract)
Traditional Chinese herb that reduces cortisol, supports sleep, and promotes relaxation without sedation.
Magnolia Bark has been used in Traditional Chinese Medicine for centuries for anxiety and digestive issues. Its active compounds, honokiol and magnolol, modulate GABA receptors and reduce cortisol. Research shows benefits for stress, anxiety, sleep quality, and even weight management through cortisol reduction. Works quickly and without next-day grogginess.
Mechanisms of Action
GABA Modulation
Enhances calming GABA activity
Cortisol Reduction
Lowers stress hormone levels
Recommended Dose
200-400mg (standardized to 2% honokiol and magnolol)
Optimal Timing
- Evening for sleep
- As needed for anxiety
Can be taken without food
Best Form
Standardized extract (honokiol/magnolol content specified)
Alternatives: Relora (magnolia + phellodendron blend)
Look for standardized extracts. Relora is a popular proprietary blend combining magnolia with phellodendron bark.
Duration
Minimum: 2 weeks
Optimal: 4 weeks
Cycling: Not required
Note: Works quickly. Take 30-60 min before bed for sleep. Can be taken during day for anxiety.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Anxiety Relief
Reduced feelings of anxiety
Sleep Improvement
Easier sleep onset and better quality
Stress Reduction
Lower perceived stress
Avoid — traditional use advises against
Who Should NOT Take This
- Known allergy or hypersensitivity to Magnolia Bark or related compounds
- Pregnancy and breastfeeding
- Concurrent use with sedative medications
Drug Interactions
May have additive sedative effects
May enhance sedation
Possible Side Effects
Tip: Reduce dose; take in evening
Tip: Usually resolves
Warnings
- May cause drowsiness — caution with driving
- Avoid combining with sedatives or alcohol
Top studies from 21+ peer-reviewed papers
Olas B • International journal of molecular sciences (2025)
“There are also no recommendations regarding their effective or safe doses for prophylaxis and the treatment of CVDs.”
Key Findings:
- In addition, there is no clinical evidence for the absorption and bioavailability of M. officinalis extracts and their main bioactive compounds in humans.
- Moreover, there are no studies simultaneously comparing the activity of magnolol and honokiol.
- Therefore, there is a need for such studies.
- There are also no recommendations regarding their effective or safe doses for prophylaxis and the treatment of CVDs.
Dobrek L et al. • International journal of molecular sciences (2023)
“It provides the mechanisms of action revealed in experimental studies of active ingredients isolated from herbal antidepressants and presents the results of selected clinical studies confirming their antidepressant effectiveness.”
Key Findings:
- Moreover, it is noteworthy that the anti-inflammatory effect is also important to the antidepressant activity of the plants mentioned above in light of the hypothesis that immunological disorders of the CNS are a significant pathogenetic factor of depression.
- This narrative review results from a traditional, non-systematic literature review.
- It briefly discusses the pathophysiology, symptomatology and treatment of depression, with a particular focus on the role of phytopharmacology in its treatment.
- It provides the mechanisms of action revealed in experimental studies of active ingredients isolated from herbal antidepressants and presents the results of selected clinical studies confirming their antidepressant effectiveness.
Szałabska-Rąpała K et al. • International journal of molecular sciences (2021)
“After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases.”
Key Findings:
- Magnolol, a polyphenolic compound found in magnolia bark, is known for its health-promoting activities and multidirectional beneficial effects on the body.
- Accordingly, the goal of this review is to systematize the available scientific literature on its beneficial effects on type 2 diabetes and its complications.
- Taking the above into consideration, the article collects data on the favorable effects of magnolol on parameters related to glycemia, lipid metabolism, or oxidative stress in the course of diabetes.
- After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases.
Poivre M et al. • Journal of Zhejiang University. Science. B (2017)
“The present review aims to summarize the literature on M. officinalis bark composition, utilisation, pharmacology, and safety.”
Key Findings:
- Much pharmacological activity has been reported for this herb and its major compounds, notably antioxidant, anti-inflammatory, antibiotic and antispasmodic effects.
- However, the mechanisms underlying this have not been elucidated and only a very few clinical trials have been published.
- In vitro and in vivo toxicity studies have also been published and indicate some intriguing features.
- The present review aims to summarize the literature on M. officinalis bark composition, utilisation, pharmacology, and safety.
Zhao X et al. • International journal of molecular sciences (2016)
“The aim of this review is to present a systematic overview of bioactive constituents in Magnolia bark that induce the prevention of obesity, hyperglycemia, hyperlipidemia, and diabetic complications, including cardiovascular, liver, and kidney.”
Key Findings:
- Oxidative stress and inflammation have been recognized as important contributors for the development of many diabetic complications, such as diabetic nephropathy, hepatopathy, cardiomyopathy, and other cardiovascular diseases.
- Several studies have established the anti-inflammatory and oxidative roles of bioactive constituents in Magnolia bark, which has been widely used in the traditional herbal medicines in Chinese society.
- These findings have attracted various scientists to investigate the effect of bioactive constituents in Magnolia bark on diabetic complications.
- The aim of this review is to present a systematic overview of bioactive constituents in Magnolia bark that induce the prevention of obesity, hyperglycemia, hyperlipidemia, and diabetic complications, including cardiovascular, liver, and kidney.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.